Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)

NCT00577707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer
Lung Cancer

Interventions

DRUG: erlotinib
DRUG: Pemetrexed
DRUG: Cisplatin
PROCEDURE: Resection

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]